MESO Competitors & Alternatives
Compare Mesoblast Ltd with similar stocks in the same industry
Biotechnology
MESO
Main Stock$13.80
Tradestie Score
55
Market Cap
$2.08B
Revenue Growth
15.3%
Analyst Upside
+153.6%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OCUL
Ocular Therapeutix, Inc.
|
$8.98
|
$1.92B | - | 67 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$87.67
|
$1.92B | - | 52 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$71.14
|
$1.90B | 421.3 | 65 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$34.06
|
$1.84B | - | 59 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.63
|
$1.81B | - | 59 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.20
|
$1.78B | - | 51 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$18.72
|
$1.78B | - | 57 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$16.12
|
$1.74B | - | 64 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$31.80
|
$1.68B | - | 61 | Compare |
|
MNKD
Mannkind Corporation
|
$3.98
|
$1.65B | - | 69 | Compare |
More MESO Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2836)
223 stocks in this industry